secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2023-09-26T23:59:59+00:00
Accession:  0001104659-23-103747
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical regains Nasdaq compliance with stockholders' equity rule
------------------------------------------------------------------------

- Previously notified Aug 15, 2023 of non-compliance with Nasdaq minimum $2.5M stockholders' equity.
- Received $19M upfront payment from license agreement on Aug 31, 2023 to address deficiency.
- On Sep 20, 2023, Nasdaq Staff confirmed the company meets the Stockholders' Equity Requirement.
- Company remains listed on Nasdaq Capital Market; delisting risk removed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465923103747/0001104659-23-103747-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465923103747/tm2326916d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-103747

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer